- A laboratory inadvertently uses a set of cefepime disks that expired two months prior but were stored under proper conditions. For an organism that is truly susceptible to cefepime, what is the most probable outcome of using these expired disks in a Kirby-Bauer assay?
Answer: Falsely resistant or intermediate results due to decreased antibiotic potency.
Correct Answer: B. Antibiotics impregnated in paper disks degrade over time, leading to a loss of potency, even with proper storage. A disk with lower-than-expected potency will not diffuse as effectively or will not inhibit growth to the same extent as a fresh disk. This results in a smaller zone of inhibition, which can cause a susceptible organism to be miscategorized as intermediate or resistant.
- A Kirby-Bauer plate testing an Enterococcus faecalis isolate against vancomycin is accidentally incubated for 36 hours instead of the standard 24 hours. The measured zone is 16 mm. The CLSI breakpoints for vancomycin are S ≥ 17 mm, I = 15-16 mm, R ≤ 14 mm. How should this result be managed?
Answer: The test is invalid due to the deviation from standard incubation time and must be repeated.
Correct Answer: C. The Kirby-Bauer test is highly standardized, and incubation time is a critical parameter. Prolonged incubation allows the bacterial lawn to continue to grow slowly as the antibiotic degrades, leading to smaller, inaccurate zone sizes. Because the test was not performed according to the mandated protocol, the results are invalid and cannot be interpreted or 'corrected'. The test must be repeated.
- A cefoxitin disk is used to screen for methicillin resistance in a Staphylococcus aureus isolate. The zone of inhibition is 23 mm (Resistant ≤ 21 mm, Susceptible ≥ 22 mm). However, the laboratory's cefoxitin QC for S. aureus ATCC 25923 on the same run was 22 mm, while the acceptable range is 23-29 mm. What is the correct interpretation and action?
Answer: Withhold the result and repeat the susceptibility test for both the patient isolate and the QC strain.
Correct Answer: C. The quality control result (22 mm) is outside the acceptable range (23-29 mm). This QC failure invalidates the entire test run. It is not permissible to interpret or report patient results from a run with failed QC. The low QC result suggests a systemic issue that could be causing all zones, including the patient's, to be falsely small. The only correct action is to investigate the cause (e.g., inoculum, agar, disks, incubator) and repeat the tests.
- A vancomycin disk diffusion test for a Staphylococcus aureus isolate from a bacteremia patient yields a zone of 18 mm (Susceptible ≥ 15 mm). However, the zone edge is indistinct, and a light sprinkling of tiny colonies is visible within the outer 2-3 mm of the zone. How should this finding be primarily interpreted?
Answer: The finding is suspicious for heteroresistant vancomycin-intermediate S. aureus (hVISA) and warrants further investigation.
Correct Answer: B. The presence of a subpopulation of colonies that can grow closer to the vancomycin disk than the main population is a classic indicator of heteroresistance (hVISA). These isolates can lead to clinical failure despite appearing susceptible by standard methods. This finding is highly significant and should prompt confirmatory testing, such as determining the MIC by Etest or broth microdilution. While contamination is a possibility, the specific pattern with vancomycin strongly suggests hVISA.
- When performing a Kirby-Bauer test on a Streptococcus pneumoniae isolate on Mueller-Hinton agar with 5% sheep blood, a zone of alpha-hemolysis is observed around the penicillin disk that is larger than the zone of growth inhibition. What is the correct procedure for measuring the zone diameter?
Answer: Remove the lid and view the plate with transmitted light to visualize the true edge of growth inhibition.
When testing Streptococcus pneumoniae for antibiotic susceptibility, you'll encounter a unique challenge because this organism requires enriched media (Mueller-Hinton with 5% sheep blood) due to its fastidious growth requirements. The alpha-hemolytic activity of S. pneumoniae can create zones of hemolysis around antibiotic disks that extend beyond the actual zone of growth inhibition, potentially confusing your measurements.
The correct approach is option D: remove the lid and view the plate with transmitted light to visualize the true edge of growth inhibition. This technique allows light to pass through the agar from below, making it easier to distinguish between areas where bacterial growth has been inhibited (which will appear clearer) versus areas where hemolysis has occurred but bacterial growth may still be present. The zone of growth inhibition—not hemolysis—is what determines antibiotic susceptibility.
Option A is incorrect because measuring the hemolysis zone would give falsely large zone diameters, leading to incorrect susceptibility interpretations. Option B is wrong because this situation doesn't make the test unreadable—it just requires proper visualization technique. The Clinical and Laboratory Standards Institute (CLSI) specifically addresses this scenario. Option C is incorrect because averaging two different biological phenomena (growth inhibition vs. hemolysis) has no scientific basis and isn't a recognized methodology.
Remember: for hemolytic organisms on blood agar, always use transmitted light to find the true growth inhibition edge. This principle applies beyond just S. pneumoniae to other hemolytic bacteria requiring blood-enriched media for susceptibility testing.
- A technologist uses standard Mueller-Hinton II Agar for a Kirby-Bauer test on a Pseudomonas aeruginosa isolate, forgetting that cation adjustment (with Ca²⁺ and Mg²⁺) is required for this organism. Quality control with E. coli ATCC 25922 is performed on the same medium and is acceptable. For the aminoglycoside tobramycin, what is the most likely consequence of this error?
Answer: A falsely susceptible result due to insufficient divalent cation concentration in the medium.
Correct Answer: A. The activity of aminoglycosides (like tobramycin) against Pseudomonas aeruginosa is significantly affected by the concentration of divalent cations. Insufficient levels of Ca²⁺ and Mg²⁺ in the agar lead to increased activity of the aminoglycoside, resulting in larger zones of inhibition. This can cause a truly resistant or intermediate isolate to be reported as susceptible. E. coli QC is less sensitive to this variation and may not detect the problem.
- A Kirby-Bauer test is performed on a clinical isolate of Proteus mirabilis. After incubation, a thin, transparent film of swarming growth is observed across the entire plate, extending into the zones of inhibition. How should the technologist measure the zone diameters?
Answer: Disregard the thin film of swarming growth and measure the diameter of the area where the heavy, confluent lawn is inhibited.
Correct Answer: C. According to CLSI guidelines for reading Kirby-Bauer plates with swarming organisms like Proteus spp., the thin veil of swarming growth should be ignored. The measurement must be taken from the edge of the heavy, confluent growth that represents the true lawn. Measuring to the edge of the swarm would lead to falsely resistant results.
- A clinical laboratory needs to perform Kirby-Bauer susceptibility testing on an isolate of Haemophilus influenzae. Which of the following represents a critical procedural modification compared to the standard protocol for testing non-fastidious organisms like E. coli?
Answer: The test must be performed on Haemophilus Test Medium (HTM) and incubated in 5% CO₂.
Correct Answer: C. Haemophilus influenzae is a fastidious bacterium that requires specific growth factors (X-factor and V-factor) not present in standard Mueller-Hinton agar. Therefore, Kirby-Bauer testing for this organism must be performed on a specialized medium called Haemophilus Test Medium (HTM). Additionally, it requires an enriched CO₂ atmosphere (5%) for optimal growth, another deviation from the standard procedure.
- A routine quality control test using E. coli ATCC 25922 shows a gentamicin zone of 12 mm (acceptable range: 19-26 mm). The ampicillin zone for the same QC test is 18 mm (acceptable range: 16-22 mm). What is the most appropriate immediate action for the technologist to take?
Answer: Withhold all patient results from the batch, check the inoculum density, and repeat the entire test panel.
Correct Answer: C. When a quality control result falls outside the acceptable range, all patient results obtained with that test run are considered invalid and must not be reported. A common technical error causing falsely small zones for multiple antibiotics (especially aminoglycosides like gentamicin) is an overly dense inoculum (too high McFarland standard). Therefore, the most appropriate first step is to check the inoculum preparation and repeat the entire test for both the QC strain and all patient isolates from that batch.
- While interpreting a Kirby-Bauer test on a Pseudomonas aeruginosa isolate, a technologist observes a large, clear zone of inhibition around the piperacillin-tazobactam disk. However, five distinct colonies are growing within this zone. The quality control test for the run was acceptable. What is the most appropriate interpretation?
Answer: The organism should be reported as resistant to piperacillin-tazobactam.
Correct Answer: C. The growth of significant colonies within a clear zone of inhibition indicates the presence of a resistant subpopulation. Even if the majority of the bacteria are susceptible, these resistant variants can be selected for during therapy, leading to clinical failure. Standard procedure is to consider the organism resistant to that antibiotic. While checking for purity is good practice, the primary interpretation based on this observation is resistance.
- A new batch of Mueller-Hinton agar plates is prepared with an average depth of 3 mm, which is below the standardized requirement of 4 mm. If these plates are used for Kirby-Bauer testing, what is the most likely effect on the measured zones of inhibition?
Answer: Zones will be falsely large because the antibiotic diffuses further laterally due to decreased vertical diffusion.
Correct Answer: A. The antibiotic diffuses from the disk in three dimensions. In agar that is too shallow (thinner), there is less volume for vertical diffusion. This causes the antibiotic to diffuse further horizontally (laterally) across the plate surface, resulting in larger zones of inhibition. This can lead to major errors where a resistant or intermediate organism is falsely reported as susceptible.
- An inoculum for a Kirby-Bauer test is accidentally prepared from a broth containing an equal mixture of a susceptible strain of E. coli and a beta-lactamase-producing, resistant strain of E. coli. What is the most likely appearance of the zone of inhibition around an ampicillin disk?
Answer: A significantly smaller, hazy zone containing many small colonies of the resistant strain.
Correct Answer: C. In a mixed population, the susceptible organisms will be inhibited by the antibiotic, attempting to form a zone. However, the resistant organisms will be able to grow within this area. The resulting appearance is not a clear zone but rather a hazy, poorly defined zone that is significantly smaller than what would be seen with a pure susceptible culture. It is often described as having growth 'up to the disk' or containing many colonies within the zone.
- A Klebsiella pneumoniae isolate from a urine sample has a zone of 16 mm for cefazolin (S ≥ 18, I = 15-17, R ≤ 14) and a zone of 25 mm for nitrofurantoin (S ≥ 17, I = 15-16, R ≤ 14). The patient has normal renal function. Which statement is the most accurate clinical interpretation?
Answer: Cefazolin may be effective because it concentrates in urine, but nitrofurantoin is a more reliable option.
Correct Answer: B. The 'Intermediate' category implies that the antibiotic may be clinically effective in body sites where it is physiologically concentrated, such as the urinary tract for many beta-lactams like cefazolin, or when a higher dosage can be used. The 'Susceptible' category implies a high likelihood of success with standard dosing. Since nitrofurantoin is fully susceptible and is also highly concentrated in the urine, it represents a more reliable and definitive treatment choice compared to the intermediate cefazolin.
- A technologist measures a zone of inhibition for meropenem against an E. coli isolate. The zone edge falls exactly between the 22 mm and 23 mm marks on the ruler. The CLSI breakpoints for meropenem are S ≥ 23 mm, I = 20-22 mm, R ≤ 19 mm. What is the most appropriate action according to standard laboratory practice?
Answer: Report the zone as 22 mm and classify the result as Intermediate.
Correct Answer: D. A standard convention in microbiology for reading Kirby-Bauer zones is to be conservative to avoid reporting false susceptibility. When a zone edge falls between two markings on a ruler or caliper, the reading should be rounded down to the lower whole millimeter. Therefore, a measurement between 22 and 23 mm should be recorded as 22 mm. Based on the provided breakpoints, a 22 mm zone falls into the Intermediate category.
- An E. coli isolate is tested for ESBL production. The zone diameter for ceftazidime is 16 mm. The zone diameter for the combination disk of ceftazidime/clavulanic acid is 23 mm. According to CLSI guidelines, a ≥ 5 mm increase in zone diameter for the combination disk is a positive test. What is the correct conclusion?
Answer: The organism is confirmed to be an ESBL producer and relevant beta-lactam results should be edited.
ESBL (Extended-Spectrum Beta-Lactamase) detection is crucial in clinical microbiology because these enzymes confer resistance to most beta-lactam antibiotics, dramatically limiting treatment options. The standard CLSI phenotypic confirmatory test relies on clavulanic acid's ability to inhibit ESBL enzymes.
Let's analyze the data: The ceftazidime zone alone is 16 mm, but with clavulanic acid added, it increases to 23 mm. This 7 mm increase exceeds the CLSI threshold of ≥5 mm, confirming ESBL production. When clavulanic acid inhibits the ESBL enzyme, the cephalosporin can effectively kill the bacteria, creating a larger zone of inhibition.
Looking at the wrong answers: Choice A misunderstands that zone size alone doesn't determine ESBL status—the comparison between zones with and without clavulanic acid is what matters. Choice B incorrectly suggests you need multiple cephalosporins; while testing multiple drugs increases confidence, one positive result meeting CLSI criteria is sufficient for confirmation. Choice C acknowledges clavulanic acid's inhibitory effect but wrongly claims this doesn't confirm ESBL presence—this is exactly what the test is designed to detect.
The correct answer is D. The ≥5 mm zone diameter increase confirms ESBL production, and according to CLSI guidelines, all beta-lactam susceptibility results should be edited to "resistant" regardless of initial zone sizes, since ESBLs can hydrolyze these antibiotics in vivo.
Study tip: Remember that ESBL confirmation depends on the zone diameter difference, not absolute zone sizes. A ≥5 mm increase with clavulanic acid = positive ESBL test.
